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Protein glycosylation with O-linked N-acetylglucosamine
(O-GlcNAc) is a post-translational modification of serine/
threonine residues in nucleocytoplasmic proteins. O-GlcNAc
has been shown to play a role in many different cellular
processes and O-GlcNAcylation is often found at sites that
are also known to be phosphorylated. Unlike phosphoryl-
ation, O-GlcNAc levels are regulated by only two enzymes,
O-GlcNAc transferase (OGT) and O-GlcNAc hydrolase
(O-GlcNAcase or OGA). So far, no obvious consensus
sequence has been found for sites of O-GlcNAcylation.
Additionally, O-GlcNAcase recognizes and cleaves all
O-GlcNAcylated proteins, independent of their sequence.
In this work, we generate and analyze five models of
O-GlcNAcylated peptides in complex with a bacterial OGA.
Each of the five glycopeptides bind to OGA in a similar
fashion, with OGA–peptide interactions primarily, but not ex-
clusively, involving the peptide backbone atoms, thus explain-
ing the lack of sensitivity to peptide sequence. Nonetheless,
differences in peptide sequences, particularly at the −1 to −4
positions, lead to variations in predicted affinity, consistent
with observed experimental variations in enzyme kinetics.
The potential exists, therefore, to employ the present analysis
to guide the development glycopeptide-specific inhibitors, or
conversely, the conversion of OGA into a reagent that could
target specific O-GlcNAcylated peptide sequences.
Keywords: β-N-Acetylglucosaminidase
(O-GlcNAcase) / GLYCAM /Molecular dynamics / O-Linked
N-acetyl-glucosamine (O-GlcNAc) / Protein glycosylation
Introduction
Since its discovery (Torres and Hart 1984), the post-translational
modification of proteins by β-O-linked N-acetylglucosamine
(O-GlcNAc) on serine or threonine residues has generated signifi-
cant interest in the field of glycobiology. The modification occurs
on nuclear and cytosolic proteins, many of which modulate cell sig-
naling (Hanover et al. 2010; Slawson et al. 2010). It is also thought
that deregulation of this modification may be involved in neurode-
generative diseases, cancer and diabetes mellitus (Hanover 2001;
Hart et al. 2007). Additionally, O-GlcNAc rapidly cycles on and off
proteins on a time scale similar to that of phosphorylation/depho-
sphorylation, and thus an interplay has been shown to exist between
protein phosphorylation and O-GlcNAcylation (Cheng et al. 2000;
Comer and Hart 2000; Kamemura et al. 2002; Zeidan and Hart
2010). Unlike phosphorylation, which is controlled by numerous
kinases and phosphatases, the addition and removal of O-GlcNAc
is controlled by only two enzymes. O-GlcNAc transferase (OGT) is
responsible for the transfer of GlcNAc from UDP–GlcNAc to the
protein, whereas O-GlcNAcase (OGA) removes it. Despite the im-
portance of this modification, very little is known about the struc-
tural relationship between these enzymes and their substrates. Nor
is it clear, how only a single hydrolase is capable of removing
O-GlcNAc from all proteins, independent of the protein sequence.
To gain an understanding of the molecular interactions re-
sponsible for the ability of OGA to tolerate multiple substrate
sequences, we modeled the structure of bacterial OGA,
Bacteroides thetaiotaomicron GH84 (BtOGA) in complex with
five O-GlcNAcylated peptides of biological interest. Notably, the
OGAs have been grouped together into the same glycoside
hydrolase family GH84 (Henrissat and Davies 1997) based on
the similarity of their N-terminal sequence domains. Specifically,
BtOGA and human OGA (hOGA) share an overall sequence
identity of >40% (Dennis et al. 2006) with the same overall 3D
structure, as such the details found from the BtOGA model can
be applied to hOGA for the development of therapeutic reagents.
Five glycopeptides, 10 residues in length, were built from
each of the following O-GlcNAcylated systems: the tumor suppres-
sor protein p53 (O-GlcNAcylated at Ser149 (Yang et al. 2006)), the
DNA packaging protein Histone H3 (O-GlcNAcylated Ser10
(Zhang et al. 2011)), a transforming growth factor binding partner
TAB1 (O-GlcNAcylated at Ser395 (Pathak et al. 2012)), as well as
c-Myc, a regulator of gene transcription (O-GlcNAcylated at Thr58
(Chou et al. 1995)). Additionally, a synthetic O-GlcNAcylated
polyalanine (poly-Ala′) peptide was included as a reference.
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It has been shown that OGA uses a substrate-assisted catalytic
mechanism, in which the N-acetyl group of O-GlcNAc adopts a
syn-conformation, in which the amide proton eclipses the proton
at C2, which aids the sugar to form the oxime transition state
(Dennis et al. 2006; Macauley et al. 2005). Several inhibitors of
OGA have been reported (Kim et al. 2006; Whitworth et al. 2006;
He et al. 2009; Macauley and Vocadlo 2010), and have been
co-crystalized with the enzyme. For this study, a model for the
conformation of O-GlcNAc in the binding site of BtOGAwas gen-
erated based on the atomic coordinates of the inhibitor PUGNAc,
a transition state mimic and O-GlcNAc analog (Perreira et al.
2006). The peptides were then conjugated to the bound monosac-
charide through a combination of molecular docking and molecu-
lar dynamics (MD) simulation.
To provide a structural and dynamic interpretation of the
observed ability of OGA to deglycosylate a variety of glycopep-
tides, each of the complexes was subjected to fully solvated MD
simulations (350 ns), followed by direct ΔG energy calculations.
We have focused on the conformational properties of these com-
plexes, rather than on the mechanism of deglycosylation, as we
are particularly interested in the ability of the enzyme to recognize
O-GlcNAc in a variety of protein contexts. We compared the con-
formation of the bound O-GlcNAcylated peptides to a recently
solved bacterial OGA homolog from Clostridium perfringens
(CpOGA) in complex with an eight residue O-GlcNAcylated p53
peptide (PDBid 2YDR) (Schimpl et al. 2012). In addition, p53
(PDBid 1TUP) (Cho et al. 1994) is the only structurally character-
ized protein where the O-GlcNAcylation site is positioned in a
fully defined loop, thus allowing us to further compare our results
(Schimpl et al. 2012).
Results
Structural stability of the BtOGA–glycopeptide complexes
Over the course of the 350 ns MD simulations, performed with
no restraints on either the protein or glycopeptides, the protein
fold remained stable; the Cα root-mean-square deviation
(RMSD) of the BtOGA in all cases reached an equilibrium
value of between 0.84 and 0.93 Å (c-Myc′: 0.93 Å, histone
H3′: 0.84 Å, p53′: 0.88 Å, poly-Ala′: 0.91 Å and TAB1′: 0.84
Å). The glycopeptides in all cases remained bound to the
protein, with the GlcNAc adopting equivalent orientations. The
ring conformation in all complexes with BtOGAwas monitored
over the course of the MD simulations. The analysis showed
that in GlcNAc-O-methyl (OMe), GlcNAc-p53, GlcNAc-Histone
H3 and GlcNAc-TAB1 the ring adopts conformations between
1S3 and
1,4B. In GlcNAc-c-Myc, the sugar ring adopts an 4H5
conformation, while in GlcNAc-poly-Ala′ the ring is more flex-
ible, adopting two conformations 4H3 (45%) and
1S3 to
1,4B
(55%). In the CpOGA–glycopeptide complexes (Schimpl et al.
2012), the ring adopts conformations between 1S3 and
1,4B.
The Cremer–Pople pucker parameters (Cremer and Pople 1975)
and cannonical ring forms are presented in Supplementary data,
Table SI and Figure S2. In addition, the dihedral angles of the
GlcNAc-Ser linkages (Φ, Ψ and χ) as well as the NAc con-
formation were monitored throughout the simulations. The ana-
lysis showed that the GlcNAc-Ser linkages, in each of the five
glycopeptides, populated comparable rotamers, whilst the NAc
group remained stable in the syn-orientation throughout (Table I).
Additionally, the average dihedral values for these angles in the
simulated p53′ and TAB1′–glycopeptide complexes were in close
agreement with those seen in the crystal structures of CpOGA
complexed with these ligands (Table I).
GlcNAc: A comparison of the hydrogen bond interactions
between the GlcNAc and OGA residues for GlcNAc-OMe as
well as all five glycopeptides is presented in Supplementry
data, Table SII. Hydrogen bonds were found between six OGA
residues and the glycan. Of those, five involved sidechain interac-
tions (D344, N339, D242, K166 and H433), whilst the remaining
was through a backbone interaction involving OGA residue G135.
The interactions between the GlcNAc residue and OGA, in both
the p53′ and TAB1′—BtOGA glycopeptide complexes, were in
good agreement with those seen in the recently reported crystal
structures for the corresponding glycopeptides in complex with
CpOGA (Schimpl et al. 2012) (Supplementry data, Table SII).
The similarity of the crystallographic and modeled complexes pro-
vided independent validation of the computational approach.
Poly-Ala′: The hydrogen bond analysis of the BtOGA—
poly-Ala′ complex showed that the most stable hydrogen bond
(26% occupancy) was formed between the sidechain of OGA
residue D243 with the backbone of Ala at the +2 position (Ala
(+2)) of the glycopeptide (positional numbering is relative to
the site of glycosylation, Figure 1A). Lower occupancy hydro-
gen bonds were observed between D243 and Ala(+1) position,
and OGAY137 and Ala(−2) (see Table II). It is notable that no
long-lived hydrogen bonds were seen between poly-Ala′ and
OGA.
c-Myc′: In the case of the c-Myc′ glycopeptide, the most
stable intermolecular hydrogen bond (31.5% occupancy) was
observed between the backbone of L56(−2) and OGA residue
D243, but unlike the case of poly-Ala′, here the interaction
involved only the backbone of D243. Weak (16.8% occupancy)
backbone-only interactions were also seen between E54(−4) and
OGA residue S245. The remaining hydrogen bonds are almost
exclusively through peptide backbone interactions and OGA;
none of these were present for over 8.1% of the simulation time.
Histone H3′: The strongest intermolecular hydrogen bond
(31.1% occupancy) in the histone H3′ glycopeptide–OGA complex
was seen between the backbone of G12(+2) of the glycopeptide
and the sidechain of OGA residue D243. This interaction and
occupancy is analogous to that seen in the case of poly-Ala′
complex. The second strongest hydrogen bond (25% occupancy)
Table I. Average dihedral angles for GlcNAc-Ser/Thr linkages in each of the
five glycopeptide–BtOGA complexes
Φa Ψa χa NAcc
c-Myc′ −51.3 (8) 168.3 (9) −57.1 (8) −67.2 (7)
Histone H3′ −78.2 (10) −176.8 (7) −63.7 (8) −64.1 (9)
p53′ −73.3 (9) −174.0 (8) −57.8 (9) −59.2 (9)
p53 X-rayb −74.6 173.2 −52.4 −52.7
Poly-Ala′ −74.8 (13) 176.2 (18) −63.7 (11) −63.3 (9)
TAB1′ −86.9 (10) 173.7 (8) −64.3 (9) −62.1 (8)
TAB1 X-rayb −67.8 165.8 −52.8 −56.5
aΦ = O5-C1-Oγ-Cβ, Ψ = C1-Oγ-Cβ-Cα, χ = Oγ-Cβ-Cα-N, in degrees, with
standard deviations in parentheses.
bFrom the p53 and TAB1 glycopeptide–CpOGA complexes (Schimpl et al.
2012).
cDihedral angle C1-C2-N-C.
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was observed between the backbone atoms of R8(−2) and the
sidechain of OGA residue R347. Additional weak hydrogen
bonds were observed between D167, Y137, H433 and D243 of
OGA and the peptide; stable for a maximum of 19.2% of the
time.
p53′: Glycopeptide p53′ formed a weak intermolecular hydro-
gen bond (32% occupancy) between the sidechain of W146(−3)
and Y550 of OGA. When compared with the recent crystallo-
graphic data of the p53 glycopeptide–CpOGA complex (Schimpl
et al. 2012), it was found that this hydrogen bond appears to
replace the stacking interaction of W146(−3) with protein residue
N298 (BtOGA N243). A comparison, of the crystallographic and
MD-derived conformations of the p53 glycopeptides with the
crystal structure of the full-length p53 protein (PDBid 1TUP)
(Cho et al. 1994), indicated that the W146 orientation from the
MD results was in good agreement with the conformation seen in
the intact p53 protein (Figure 2). The backbone conformation of
the MD-derived p53′ glycopeptide gave rise to an average RMSD
Fig. 1. (A) Five polypeptides were built in extended conformations using the Maestro builder from Schrödinger. Sites of glycosylation are indicated with a star and
are positioned at Thr58 (c-Myc), Ser10 (Histone H3), Ser149 (p53), Ser5 (poly-Ala′) and Ser395 (TAB1). (B) The top docked conformation of each peptide was
used as a starting point for MD. (C) Ribbon representation of the peptide structures from the 350 ns simulation aligned onto the GlcNAc residue from the bound p53
glycopeptide – CpOGA crystal structure. The snapshots have been selected every 3.5 ns. The peptides are coloured as follows; c-Myc′ (purple), Histone H3′ (red),
p53′ (blue), poly-Ala′ (green), TAB1′ (cyan), with the p53-crystal glycopeptide in yellow.
Origin of the sequence independence of O-GlcNAcase
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of 1.4 Å relative to the same region in the intact protein, whereas
the data from CpOGA crystal structure resulted in an RMSD
value of 2.2 Å. Other OGA residues predicted by MD to make
hydrogen bonds to the p53′ peptide include H433, D243, Y137
and K166; however, these were again short lived.
TAB1′: As seen in the case of poly-Ala′, in TAB1′ the most
stable intermolecular hydrogen bond (24.3% occupancy) was
again a peptide backbone interaction, specifically between
A397(+2) and the sidechain of OGA residue D243. No other
interactions existed for >8% of the total simulation time.
Structure and dynamics of the bound glycopeptides
To assess the presentation and conformation of each of the gly-
copeptides, obtained from the MD simulations, with that seen
in the crystal structure of the p53 glycopeptide–CpOGA
complex (Schimpl et al. 2012), the glycan atoms in the glyco-
peptides were aligned onto the crystallographic coordinates of
GlcNAc in the complex (Figure 1C). This alignment indicated
that, in all cases, despite the difference in sequences, each
peptide backbone adopted a similar “V”-shaped conformation;
comparable with that seen for glycopeptide fragments of p53,
TAB1 and hOGA in complex with CpOGA (Schimpl et al.
2012). This “V”-shaped conformation is likely stabilized by a
combination of intermolecular interactions, between the pep-
tides and those BtOGA residues identified from both the
hydrogen bond and the binding interaction analyses, as well as
intramolecular bonds within the glycopeptide. In addition to
the intermolecular interaction, discussed previously, an analysis
of intramolecular interactions showed that all glycopeptides,
with the exception of poly-Ala′, form, primarily, but not exclu-
sively, mainchain hydrogen bonds between residues at the −1
or −2 positions with opposing residues at the +1, +3 or +4
positions in the glycopeptide (see Supplementary data,
Table SIII). Specifically, in the complex of BtOGA with the
p53′-glycopeptide, a hydrogen bond was observed (3.0 Å, 76%
occupancy) between the carboxylate of D(−1) and the main-
chain nitrogen atom of T(+1). A similar interaction has been
reported in the crystal structure of the p53 glycopeptide with
CpOGA (2.5 Å) (Schimpl et al. 2012). That this interaction
formed spontaneously in the MD data, which was initiated in-
dependent of the CpOGA–p53 complex, adds to the credibility
of the general approach taken here to model the BtOGA–glyco-
peptide complexes. Similarly, a bond was observed (2.9 Å,
53% occupancy) in the TAB1′–glycopeptide complex between
the mainchain carbonyl oxygen atom in Y(−1) and the side-
chain hydroxyl in S(+1) of the glycopeptide. Interestingly, this
interaction is not seen in the crystal structure of the TAB1–gly-
copeptide in complex with CpOGA (average distance 6.7 Å)
(Schimpl et al. 2012); most likely due to the glycopeptide ter-
minating at Ser at the +1 position, as opposed to being part of a
longer peptide (10 residues) in our model. In the Histone H3′
glycopeptide, a weak hydrogen bond was seen (3.0 Å, 20% oc-
cupancy) between the −1 position (K, mainchain N) and the −4
position (T, mainchain carbonyl). Similarly, in the c-Myc′ gly-
copeptide, a weak hydrogen bond was predicted to exist (3.1 Å,
26% occupancy) between the backbone atoms at the −2 pos-
ition (L, mainchain carbonyl) and the +3 position (L, main-
chain N). In contrast to the cases of p53′ and TAB1′, in which
the hydrogen bond spans only the glycosylated residue, in
Histone H3′ and c-Myc′, the hydrogen bond spans three resi-
dues, presumably weakening the interaction in the latter cases.
Table II. Intermolecular hydrogen bond occupancies between BtOGA and the
peptide moieties for each of the five glycopeptide–OGA complexes
Donor H-X Acceptor Occupancy
c-Myc′
L(−2)-Main D243-Main 31.5
S245-Main E(−4)-Main 16.8
E(−4)-Main S245-Main 8.1
H433-Side T*(0)-Main 7.5
P(+1)-Main D243-Side 7.1
S245-Side E(−4)-Side 6.5
Histone H3′
G(+2)-Main D243-Side 31.1
R347-Side R(−2)-Main 25.4
R(−2)-Side D167-Side 19.2
Y137-Side S*(0)-Side 13.5
H433-Side S*(0)-Main 10.9
T(+1)-Main D243-Side 5.4
p53′
W(−3)-Side Y550-Side 31.9
H433-Side T(+1)-Side 18.3
L(−4)-Main D243-Main 14.8
Y137-Side S*(0)-Side 8.3
W(−3)-Side K166-Main 7.8
V(−2)-Main Y137-Side 6.7
T(+1)-Side H433-Side 5.9
Poly-Ala′
A(+2)-Main D243-Side 26.0
A(+1)-Main D243-Side 5.5
A(−2)-Main Y137-Side 5.4
TAB1′
A(+2)-Main D243-Side 24.3
H433-Side Y(−1)-Side 7.9
Q(+3)-Side W286-Side 6.9
Y137-Side S*(0)-Side 6.7
aBased on a maximum donor–acceptor distance of 3.5 Å with a minimum
occupancy of 5%.
Fig. 2. Ribbon representation of both, the most populated p53′ glycopeptide
(blue) and the p53 glycopeptide from the CpOGA complex 2YDR (yellow),
were aligned onto the corresponding sequence (Leu 145 to Gly 151) in the p53
protein crystal (PDBid 1TUP) (grey). Trp 146 of p53 (-3 position in the
glycopeptides) is shown in stick with the GlcNAc residue removed for clarity.
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With regard to intramolecular glycan–peptide interactions, it is
notable that in each case a hydrogen bond was formed between
the hydroxymethyl group (GlcNAc-O6) and the backbone of
the glycosylated serine (Ser-N). This hydrogen bond (3.4 Å)
was also seen in the p53′ glycopeptide–CpOGA complex
(Schimpl et al. 2012). GlcNAcylation via threonine, as in
c-Myc′, appears to abolish this interaction.
An analysis of the RMSD of the peptide backbones was per-
formed to quantify the conformational distribution for each
peptide (Figure 3A), relative to the initial structure in the MD
Fig. 3. Backbone atom (CA, C, O, N) RMSD values for each peptide throughout the 350ns MD as a function of time. (A) Average RMSD of each peptide relative to
its starting conformation. (B) Each peptide relative to the backbone conformation of the p53 glycopeptide conformation from the crystal structure (PDBid 2YDR).
The RMSD values are coloured as follows; c-Myc′ (purple), Histone H3′ (red), p53′ (blue), poly-Ala′ (green), TAB1′ (cyan).
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simulations. This analysis indicated that Poly-Ala′ was the most
flexible glycopeptide, with the average RMSD values being: 1.0
Å (poly-Ala′), 0.8 Å (c-Myc′), 0.6 Å (Histone H3′), 0.6 Å (p53′)
and 0.5 Å (TAB1′). The RMSD analysis (Figure 3B), relative to
the conformation of the p53–glycopeptide in complex with
CpOGA (Schimpl et al. 2012), indicated that the backbone con-
formations of each of the glycopeptides are similar: 2.6 Å
(c-Myc′), 1.9 Å (Histone H3′), 2.0 Å (p53′), 1.5 Å (poly-Ala′)
and 1.8 Å (TAB1′). Additionally, to identify similar conform-
ational features sampled during the simulation of each glycopep-
tide, a clustering analysis was performed on the five MD data
sets. The cluster analysis revealed that the top three clusters from
each peptide cover over 75% of the total conformational space
sampled. Of all of the glycopeptides, poly-Ala′ and c-Myc′ dis-
played the highest degree of structural diversity significantly
populating at least two clusters (see Table III), whereas all of the
other glycopeptides could be characterized by a single dominant
cluster. The RMSD of each peptide, from the most populated
cluster, relative to the conformation of the p53–glycopeptide in
complex with CpOGA (Schimpl et al. 2012), was comparable
with those seen in the average RMSD analyses, and also showed
that the peptide backbone conformations are all within 1.7 Å of
each other (Table III).
Structure and dynamics of the free glycopeptides
To gain an understanding of the extent to which the free glyco-
peptides in solution exist in conformations appropriate for
binding to the BtOGA, independent MD simulations (500 ns)
were performed on each of the five glycopeptides. An analysis
of the intramolecular hydrogen bonds in each system indicated
that p53′ and TAB1′ displayed transient interactions for 29%
of the simulations (see Supplementary data, Table SIV). The
other glycopeptides appeared to be even less-ordered. The
interactions within p53′ were similar to those seen in the bound
peptide, whereas in TAB1′ they were unique to the free peptide.
Thus, only in the case of p53′ does the free peptide appear to
populate to some extent conformations comparable with those
seen in the bound state. It is notable also that intramolecular
interactions between the glycan and residues at the +1 or −1
positions were observed in the free glycopeptides, similar to
those seen in the bound forms, but that even in the case of p53′
these interactions were transient.
To further quantify the conformational similarities between
the bound and free glycopeptides, the bound conformation of
each peptide, as extracted from the dominant cluster, was com-
pared with the solution conformations. The resulting RMSD plots
for the free glycopeptides, relative to the bound conformaiton, in-
dicate that p53′ exhibits relatively low RMSD values (of 2–4
Å), further supporting the idea that the p53′ glycopeptide exists in
a conformation similar to that of the bound (Supplementry data,
Figure S3). In contrast, in the case of TAB1′, the internal hydro-
gen bonds for the free glycopeptide are associated primarily with
a conformation that is significantly different from that seen in the
bound state (RMSD 4–5 Å). Neither histone H3′ nor poly-Ala′
appear to adopt conformations similar to the bound forms,
however, c-Myc′, despite the absence of stable internal hydrogen
bonds, also adopts conformations in solution that are similar to
the bound form (RMSD2–5 Å).
Binding free energy analysis
Per-residue binding free energy calculations (molecular mechanics–
generalized born surface area (MM–GBSA)) were carried out on
GlcNAc-OMe in complex with BtOGA, as well as the five glyco-
peptide–BtOGA complexes. This allowed us to separate and quan-
tify the contributions made by the GlcNAc and the peptide
portions of the glycopeptides, as well as to identify which BtOGA
residues make a significant contribution to glycopeptide affinity.
BtOGA per-residue binding energy contributions. In agreement
with the hydrogen bond analysis of the OGA–glycopeptide
interactions, the MM–GBSA data showed that the five BtOGA
residues (D344, N339, D242, K166 and H433), which make
sidechain interactions with the glycan, rank among the highest
contributors to binding affinity (Figure 4 and Supplementary
data, Table SV). Additionally, the MM–GBSA analysis for the
OGA–GlcNAc-OMe complex found that protein residues (W337,
Y282, N372, Y137, V314 and V342) contribute toward binding
GlcNAc through a combination of van der Waals and hydrophobic
interactions. Other residues that were predominantly associated
with the peptide portion of the glycopeptides were also
identified; for example D243 (see Figure 4 and Supplementary
data, Table SV). Notably, residue Y137 showed a markedly greater
contribution to binding for all glycopeptides, compared with that
seen for its interaction with GlcNAc-OMe alone. Further, the
contribution from Y137 varied among the glycopeptides,
making a significantly stronger interaction with p53′ (−8.6 kcal/
mol), which may be compared with values for histone H3′
(−5.5 kcal/mol), c-Myc′ (−5.0 kcal/mol), TAB1′ (−4.5 kcal/mol),
poly-Ala′ (−3.9 kcal/mol) and GlcNAc-OMe (−1.2 kcal/mol).
Table III. Clustering analysisa for each of the five glycopeptides
Cluster Cluster population RMSD
c-Myc
1 56 2.9
2 30 2.3
3 6 3.0
Total 91
Histone H3
1 79 1.9
2 9 1.7
3 5 2.0
Total 92
p53′
1 92 1.9
2 5 2.2
3 2 2.2
Total 99
Poly-Ala′
1 36 1.4
2 27 1.4
3 12 1.3
Total 75
TAB1′
1 91 1.8
2 5 1.5
3 2 1.5
Total 98
aRelative to the backbone conformation of the p53 glycopeptide in complex
with CpOGA (Schimpl et al. 2012) and the structure with the median RMSD in
the cluster. Populations in percent, distances in Angstroms.
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This enhancement stems from hydrogen bonding with the
glycosylation site Ser or Thr residues, common to each
glycopeptide, as well as through van der Waals interactions
with glycopeptide residues at the −2 and −3 positions.
Similarly, residue W286 contributes to peptide binding in all
cases, principally through van der Waals interactions with
residues at the +2 to +4 positions (TAB1′ (−5.0 kcal/
mol) > poly-Ala′ (−3.7 kcal/mol) > p53′ (−3.1 kcal/mol) histone
H3′ (−2.0 kcal/mol) > c-Myc′ (−1.3 kcal/mol) > GlcNAc-OMe
(−0.2 kcal/mol)). Residue H433 also contributes to binding in
all of the peptides; interestingly the interactions with H433
ranks the glycopeptides in an inverse order relative to that seen
for W286, namely c-Myc′ (−2.6 kcal/mol) > histone H3′ (−2.5
kcal/mol) > p53′ (−1.7 kcal/mol) >TAB1′ (−1.3 kcal/mol) > poly-
Ala′ (−1.0 kcal/mol) >GlcNAc-OMe (−0.7 kcal/mol). This suggests
that W286 and H433 counter balance each other in terms of
peptide specificity.
Certain BtOGA residues were also found to be of particular
importance to a subset of glycopeptides (Figure 4). For example,
residues Y550 (−2.9 kcal/mol), R347 (−2.3 kcal/mol) and S245
(−2.3 kcal/mol) each contribute significantly to the affinity
of histone H3′. Residue Y550 interacts favorably with histone
H3′ residue R(−2), primarily through van der Waals interac-
tions. As might be expected, the interaction between R347 and
R(−2) is electrostatically repulsive; however, it is predicted to
be net favorable, as a result of desolvation effects. This suggests
that mutation of R347, to either D or E, or to an aromatic residue,
may lead to increased binding specificity for histone H3′. As in
the case of histone H3′, residue Y550 also contributes to the affin-
ity of p53′ (−1.7 kcal/mol), primarily through van der Waals
interactions with W(−3). Finally, residues S245 (−2.4 kcal/
mol) > I244 (−2.7 kcal/mol) > Q210 (−1.8 kcal/mol) are each
involved in favorable interactions with c-Myc′ at E(−4).
Glycopeptide per-residue binding energy contributions. In
order to define the contributions from each residue in the five
glycopeptides, a per-residue decomposition of the MM–GBSA
data was performed (see Table IV for total energy interactions and
Supplementary data, Table SVI for the per-residue breakdown).
Specifically, over 50% of the total binding free energy for each of
the five glycopeptides comes directly from interactions involving
Fig. 4. The middle structure from each cluster analysis, of c-Myc′ (purple), Histone H3′ (red), p53′ (blue), poly-Ala′ (green) and TAB1′ (cyan) are shown in complex
with OGA. The per-residue binding interactions for the OGA residues are represented as a colour scale; from lowest (most attractive) (red) to highest (least attractive)
(grey) binding interaction energy value. The OGA residues that are most significant to peptide binding are shown for each complex.
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O-GlcNAc. The significance of the GlcNAc moiety in driving
glycopeptide binding has similarly been shown through kinetic
studies of hOGA with various O-GlcNAcylated substrates (Shen
et al. 2012). Interestingly, the binding energy from the GlcNAc
falls into two distinct categories. For the glycopeptides; c-Myc′,
Histone H3′ and p53′, the GlcNAc contributed essentially
equivalent interaction energies (−27.0 to −27.9 kcal/mol), whereas
for the poly-Ala′ and TAB1′ glycopeptides, the glycan contributed
−22.9 and −23.8 kcal/mol, respectively (Table IV). The loss in
affinity in the latter two cases is a direct result of weakened
electrostatic interactions (decreased by 4–5 kcal/mol) with the
glycan. The analysis of the hydrogen bond interactions for these
systems suggests that this is a result of weaker interactions
specifically with residues D344 and N339, as indicated by both
slightly lower occupancy and larger distances of the hydrogen
bonds (Supplementary data, Table SII). Closer inspection indicates
that the glycan, in the poly-Ala′ and TAB1′ glycopeptide
complexes, is more mobile than in the other three complexes;
the average positional RMSD for the nonhydrogen atoms in
GlcNAc for the poly-Ala′ (0.82 Å) and TAB1′ (0.61 Å)
complexes are slightly higher than for the GlcNAc in the other
three complexes (c-Myc′: 0.53 Å, histone H3′: 0.41 Å, and p53′:
0.51 Å).
The peptides (not including the GlcNAc) contribute (−18.7
to −24.4 kcal/mol) to the total interaction energy; or up to 50%
of the total binding affinity. As might be expected on the basis of
relative flexibilities, the interaction energies associated with the
GlcNAc residues are much less variable than those of the pep-
tides. These data suggest that peptide residues in the vicinity of
the glycosylation site (±5 residues) can enhance glycopeptide af-
finity, and also that loss of the glycan from the peptide, by enzym-
atic cleavage, would markedly reduce the affinity of the products.
Notably, as in the case of the GlcNAc residues, the glycosylation
site contributed similar values in each complex (an average of
−2.9 ± 0.7 kcal/mol), with no significant differences being
observed for Ser or Thr (c-Myc′) residues. In the poly-Ala′ refer-
ence system, the residues in the +1 to +5 positions, relative to the
glycosylation site, contribute −10.0 kcal/mol to the binding
interaction. In the cases of the other four glycopeptides, residues
in the +1 to +5 positions make weaker interactions with BtOGA
(histone H3′: −8.0 kcal/mol, p53′: −7.8 kcal/mol, c-Myc′: −4.9
kcal/mol), relative to poly-Ala′, with the exception of TAB1′
(TAB1′: −11.1 kcal/mol). In contrast, relative to poly-Ala′ (−6.2
kcal/mol), residues in the −1 to −4 positions consistently contrib-
ute significantly to the interaction energies (p53′: −16.0 kcal/mol,
histone H3′: −13.0 kcal/mol, c-Myc′: −11.5 kcal/mol, TAB1′:
−10.3 kcal/mol).
Discussion
Here we have extended the simulations to systems for which ex-
perimental data do not exist. The new structural information
provides a fundamental understanding of the manner in which
OGA tolerates variations in peptide substrate sequence. It is
also important to note that interaction energies are highly sensi-
tive to the 3D structure of the complex, and for these reasons
we have placed considerable emphasis on validating and inter-
preting the structural properties of the BtOGA–glycopeptide
complexes.
The computational analyses indicate that each of the five gly-
copeptides can adopt comparable conformations when bound
to the enzyme and that the interaction energies of each complex
were remarkabley similar, spanning a range of <5 kcal/mol.
The bound complexes are in good agreement with recently
reported data for the complex between the bacterial OGA
homolog from C. perfringens (CpOGA) in complex with an
O-GlcNAcylated p53 peptide (PDBid 2YDR) (Schimpl et al.
2012). The fact that poly-Ala′ behaved similarly to the other
four natural glycopeptides suggests that the interactions with
BtOGA are structurally nonspecific. The occupancy analysis of
the hydrogen bond network revealed that none of the peptides
formed stable inter- or intramolecular hydrogen bonds. This is
not unexpected, given the highly dynamic nature of the pep-
tides. Nevertheless, the analyses suggested that the “V”-shaped
conformation of each of the glycopeptides was stabilized to
greater or lesser extents by weak intramolecular interactions
spanning the glycosylation site, as well as by a limited number
of intermolecular interactions.
Although stacking between Y137 and the peptide backbone
was noted by Shimpl et al., no such stacking was observed
during the simulations of the BtOGA glycopeptide complexes
(Supplementary data, Table SVII). Rather, the interaction energy
associated with Y137 stems from less-ordered vdW contacts with
the glycopeptides. The lack of stacking during the MD simula-
tions indicates that there is no hydrophobic or van der Waals
driving force for such an orientation. The lack of a stable stacked
geometry might also arise from the inability of the classical force
field to capture effects arising from π to π orbital overlap.
A per-residue analysis of the energetic contributions of BtOGA
to binding, from both hydrogen bonding and nonpolar interac-
tions, indicated that a small subset of residues (D344, N339,
D242, K166, H433, W337, Y282, N372, Y137, V314 and V342)
is responsible for binding the glycan. Similarly, the analysis indi-
cated that four BtOGA residues (Y137 >D243 ≈W286 >H433)
were predominantly responsible for binding the peptide portion
for all of the glycopeptides. Our results are in good agreement
with the experimentally observed loss of enzymatic activity
observed for BtOGA mutants (D242A/N, D243A/N, N372A,
Table IV. Total component binding free energiesa for each of the five
glycopeptides.
Moiety Van der
Waals
Electrostatic Polar
Desolvation
Nonpolar
Desolvation
Total
Interaction
c-Myc′
GlcNAc −13.0 −45.9 34.3 −2.4 −27.0 (2.2)
Peptide −21.8 37.9 −32.5 −2.9 −19.1 (6.0)
Histone H3′
GlcNAc −12.9 −46.8 34.2 −2.3 −27.9 (1.7)
Peptide −25.9 −175.6 180.7 −3.8 −24.4 (7.5)
p53′
GlcNAc −13.1 −45.6 33.6 −2.3 −27.4 (1.7)
Peptide −31.0 51.2 −39.8 −4.6 −24.2 (7.0)
Poly-Ala′
GlcNAc −12.3 −41.5 33.2 −2.3 −22.9 (4.7)
Peptide −23.8 −3.8 12.2 −3.5 −18.7 (7.6)
TAB1′
GlcNAc −13.5 −40.4 32.4 −2.3 −23.8 (1.9)
Peptide −27.0 −13.6 20.4 −4.2 −24.4 (7.9)
aIn kcal/mol with standard deviation in parentheses
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Y137F and Y282F) (Dennis et al. 2006), as well as CpOGA
mutant D401A (BtOGA D344) (Rao et al. 2006). It has also been
reported that mutation of the conserved Y69 in hOGA (BtOGA
Y137) to any residue other than F led to a loss in enzymatic activ-
ity (Schimpl et al. 2012). Given that the remaining peptide resi-
dues contribute to affinity through both backbone and sidechain
interactions, it is unclear to what extent mutations at these posi-
tions would affect affinity or modulate enzyme Km values. The
per-residue analysis also identified residues which contributed spe-
cifically to affinity for each of the glycopeptides. Such data enable
the prediction of sites whose mutation may lead to significant pre-
ferences for one substrate over another. For example, mutation of
BtOGA R347 to either a negatively charged, or aromatic, residue
could potentially lead to an increased affinity and specificity for
histone H3′.
Taken together, the MM–GBSA data indicate that the affinity
for substrate varies as a function of peptide sequence, despite
the fact that there are no strong recognition motifs associated with
any of the peptides. This observation would be expected to lead to
variations in the enzyme Km values, as observed experimentally
(Schimpl et al. 2012). Consistent with interpretations of the crystal
structures (Schimpl et al. 2012), affinity contributions are made by
peptide residues near the GlcNAc site, but here we also see signifi-
cant contributions from residues as distal as the −4 position.
Although the glycopeptides all adopted grossly similar “V”-shaped
conformations, none displayed persistent internal hydrogen bonds.
Thus it is uncertain to what extent internal structuring of the
peptide contributes to the affinity of the interactions, or to the Km of
the enzyme, as has been proposed (Schimpl et al. 2012).
Conclusion
Here we have presented an atomic-level analysis of the structure
and dynamics of the binding interaction between a bacterial
OGA homolog in complex with five GlcNAcylated peptides of
biological interest. The primary motivation for the research was
to develop an understanding of the unique lack of substrate se-
quence specificity displayed by OGA. The MD simulations
show that despite the differences in sequence, all of the glyco-
peptides adopted a similar conformation when bound to OGA,
consistent with limited experimental data (Schimpl et al. 2012),
but nevertheless retain considerable internal flexibility. This
flexibility is also thought to occur in the region spanning the
sites of known O-GlcNAcylated proteins, and as such there
are currently no protein structures available, with the excep-
tion of p53 (PDbid 1TUP), where these regions are fully
defined (Schimpl et al. 2012). This observation has implica-
tions not only for the action of the hydrolase OGA, but also
potentially for the specificity of its cognate partner, the trans-
ferase OGT.
The theoretical approach taken here enabled us to quantify the
relative importance of specific and nonspecific interactions. The
data show that the specificity of OGA for the GlcNAcylated pep-
tides arises primarily from strong conserved interactions with the
glycan; nevertheless, nonspecific interactions with the peptidic
component of the substrates contribute significantly to affinity.
This observation provides a clear explanation for the ability of
this enzyme to tolerate a range of polymorphisms in the vicinity
of the glycosylation site in the substrate. The analysis also indi-
cates that variations in observed Km values (Schimpl et al. 2012)
are a natural consequence of affinity contributions from non-
specific interactions with the substrate. The potential exists there-
fore to employ the present analysis to guide the development
glycopeptide-specific inhibitors, or conversely, the conversion of
OGA into a reagent that could target specific O-GlcNAcylated
peptide sequences.
Computational methods
MD simulations
All MD simulations were carried out using version 4.04 of the
Groningen machine for chemical simulations (GROMACS)
(Hess et al. 2008) or assisted model building with energy refine-
ment (AMBER)12 (Case et al. 2005) software packages. All
calculations employed the AMBER99SB (Cornell et al. 1995)
parameters for the protein augmented by the glycans and glyco-
proteins in AMBER (GLYCAM)06g (Kirschner et al. 2008)
parameters for the carbohydrate. The total charge was neutralized
by addition of explicit Na+ or Cl− counter ions as required. Each
system was solvated with TIP3P water (Jorgensen et al. 1983) in
a cubic simulation box (120 Å per side). The positions of all
water molecules, counterions and all hydrogen atoms were opti-
mized through 10,000 steps of steepest descent energy minimiza-
tion. During energy minimization and MD equilibration the
nonhydrogen atoms were restrained with a force constant of
1000 kJ/mol/nm2.
A step-wise protocol was employed for MD equilibration be-
ginning with heating in the NVTensemble to 300 K over 100 ps.
Subsequently, water, hydrogen atoms and counter ions were equi-
librated for a further 200 ps in the NPT ensemble at 300 K at a
pressure of 1 bar. Restraints were then removed from the side-
chains of the protein–ligand complexes and the system equili-
brated for a further 1 ns. During the final equilibration phase (2
ns), all atoms were released from positional restraints. In all simu-
lations, the linear constraint solver (LINCS) was used to constrain
all hydrogen-containing molecules (Hess et al. 1997), permitting
an integration step of 2 fs. The temperature was held constant at
300 K by a Langevin thermostat with a coupling time constant of
0.1 ps. Electrostatic interactions were treated with the Particle–
Mesh Ewald (PME) algorithm (Darden et al. 1993). Cut-off
values for Coulomb interactions were set to 12 Å, while van der
Waals interactions were switched off between 10 and 11 Å.
Protein coordinates were obtained from the crystal structure of
the bacterial OGA from B. thetaiotaomicron (BtOGA), in complex
with the GlcNAc transition state mimic inhibitor PUGNAc
(PDBid: 2VVS) (Macauley et al. 2008). The N-terminal domain
between L5 and P125, located between 28 Å and 54 Å from the
binding site, was removed to reduce the computational demand.
The N- and C-terminal residues (Ser126 and Ala586) were capped
with acetyl (ACE) and N-methyl (NME) groups, respectively.
Aside from residue D243 (D175 in hOGA), which is known to be
protonated (Çetinbaş et al. 2006), the protonation state of all other
ionizable residues was chosen to reflect their standard proton-
ation at pH 7. All crystallographic water molecules were
removed and missing hydrogen atoms were added to the struc-
ture using pdb2gmx (Feenstra et al. 1999). Where possible,
protonation of His residues at the - or δ-nitrogen atoms was
based on optimal hydrogen bonding interactions; otherwise a
default of His-δ was assumed.
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Generation of the glycopeptide–BtOGA complexes
The conformation of the bound native GlcNAc ligand was un-
ambiguously determined based on the PUGNAc coordinates. It
has previously been shown that the common anti-conformation
of the NAc group in PUGNAc does not permit it to fit into the
binding site of the BtOGA (Rao et al. 2006), thus the NAc group
of the GlcNAc residue was rotated from anti to syn, comparable to
the orientation seen for the oxime in the BtOGA–PUGNAc
complex (Figure 5A). Syn and anti refer to values of 0° and 180°
with respect to the H2-C2-C-N torsion angle; however, as hydro-
gen atoms are not routinely reported in crystal structures, these
orientations have alternatively been defined here in terms of
C1-C2-N-C for which syn = −60° and anti = 120°. A 3D structure
for GlcNAc-β-O-Ser was built using the GLYCAM webtool
(Woods 2005–2013) and modified using Maestro (Maestro 2011)
to generate three rotamers of the serine side chain (χ1 = 40.7,
170.6, and −49.1°, see Figure 5B), as identified from the
Dynameomics database (Day et al. 2003; Beck et al. 2008; Kehl
et al. 2008; Simms et al. 2008). The N- and C-terminal residue was
capped for all glycopeptides with an acetyl (ACE) or N-methyl
(NME) group, respectively. To determine the preferred conform-
ation of the GlcNAc-β-O-Ser linkage, three initial MD simulations
of this glycopeptide in complex with BtOGA were carried out.
Each simulation was initiated with the χ1 angle of the Ser sidechain
in one of the three possible stable rotamers.
Following MD simulations, the most populated GlcNAc-β-
O-Ser rotamer was identified (ϕ/ψ/χ1 ≈−61.3/−179.5/−77.9°; see
Figure 5C and Supplementary data, Figure 1), and used to define
an initial orientation of the GlcNAc moiety relative to the peptide
backbone for use in docking each of the GlcNAcylated peptides
(c-Myc′, histone H3′, p53′, TAB1′ and a poly-Ala′) to BtOGA.
Molecular docking was performed with Autodock Vina (AD
Vina) (Trott and Olson 2010), employing the iterated local
search global optimizer algorithm (Baxter 1981; Abagyan et al.
1994). Structures for the five fully extended glycopeptides were
generated using Maestro (Maestro 2011), and docked into the
BtOGA structure, while maintaining the GlcNAc-β-O-Ser
linkage at the preferred rotamer values, as defined above. All
other backbone and sidechain torsion angles in the glycopep-
tides were allowed to be flexible. The graphical user interface
program AutoDock Tools (Sanner 1999) was used to prepare
the structures for all docking simulations. To prepare the
BtOGA crystal structure for docking, crystallographic water
molecules, as well as the co-crystallized inhibitor, PUGNAc,
were removed. Polar hydrogen atoms were added where neces-
sary with AutoDock Tools. The docking region was selected by
centering a grid box (35 Å per side) on the Cα atom of the nu-
cleophile residue D243. The optimal glycopeptide conform-
ation from each of the five dockings was determined by
searching the ranked docking poses for the lowest energy struc-
ture; in which the GlcNAc was placed in a pose comparable
with that seen in the MD simulations of the GlcNAc-β-O-Ser
complex (Figure 1B). The five BtOGA–glycopeptide com-
plexes were employed for subsequent MD simulations.
Simulations of the free glycopeptides were initiated from the
most populated conformation of the bound glycopeptides.
Analysis
The conformational properties of each of the five peptides was
analyzed in terms of RMSD of the peptide backbone atoms
(Cα, N, C, O) employing visual molecular dynamics (VMD)
(Humphrey et al. 1996). The RMSD values for each peptide was
calculated relative to the first time step of the MD simulation,
and also with reference to the experimental coordinates reported
recently for the p53 glycopeptide bound to CpOGA. The
Cremer–Pople-puckering parameters (Cremer and Pople 1975)
of the GlcNAc ring were monitored throughout each MD using
the GROMACS (Hess et al. 2008) tool g_puckering. Clustering
analyses of the peptide conformations were performed using the
GROMACS tool g_cluster, employing the Gromos Algorithm
(Daura et al. 1999) using an RMSD cut-off of 1.0 Å. Stacking
interactions were monitored using the GROMACS (Hess et al.
2008) tool g_sgangle to measure the angle and distance between
two specified groups. An analysis of the hydrogen bond network
was carried out for each complex using VMD (Humphrey et al.
1996) with a distance cut-off of 3.5 Å and a minimal occupancy
of 5%. Binding free energies were calculated with the single-
trajectory MM–GBSA method (Kollman et al. 2000, Srinivasan
et al. 1998), with average values computed from an ensemble of
100 uncorrelated snapshots collected every 3.5 ns from the 350
ns trajectory. Before the analyses, all water molecules were
removed from each complex, and the solvation energy approxi-
mated through the generalized Born (GB) implicit solvation
model (igb = 2) (Onufriev et al. 2004). This approach has been
applied by us (Kadirvelraj et al. 2006, Kadirvelraj et al. 2011)
and others (Bryce et al. 2001) for the analyses of carbohydrate–
protein affinity.
Fig. 5. (A) β-OMe-GlcNAc(z), shown as sticks with pink carbons, was superimposed onto PUGNAc, shown as grey sticks, in the OGA (PDBid 2VVS) binding site,
shown as grey cartoon. (B) The three β-Ser-O-GlcNAc(z) g+ (green), t (cyan), g- (pink) rotamers, prior to MD. C) β-Ser-O-GlcNAc(z) rotamers after 10 ns
simulation.
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Supplementary Data
Supplementary data for this article is available online at http://
glycob.oxfordjournals.org/.
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